Social Genomics of Methamphetamine Use, HIV Viral Load, and Social Adversity. Issue 9 (23rd November 2021)

• Record Type: Journal Article
• Authors: Li, Michael J; Richter, Emily I; Okafor, Chukwuemeka N; Kalmin, Mariah M; Dalvie, Shareefa; Takada, Sae; Gorbach, Pamina M; Shoptaw, Steven J; Cole, Steven W
• Is Part Of: Annals of behavioral medicine. Volume 56:Issue 9(2022)
• Page Start: 900
• Page End: 908
• Publication Date: 2021-11-23
• Subjects: Gene expression -- Immune system -- Transcriptome -- Methamphetamine -- HIV -- Viral load; Medicine and psychology -- Periodicals; Sick -- Psychology -- Periodicals; Behavioral Medicine; 616.0019
• DOI: 10.1093/abm/kaab096
• Languages: English
• ISSNs: 0883-6612

Abstract

Abstract: Background: Social genomics has demonstrated altered inflammatory and type I interferon (IFN) gene expression among people experiencing chronic social adversity. Adverse social experiences such as discrimination and violence are linked to stimulant misuse and HIV, conditions that dysregulate inflammatory and innate antiviral responses, leading to increased HIV viral replication and risk of chronic diseases. Purpose: We aimed to determine whether methamphetamine (MA) use, unsuppressed HIV viral load (VL) (≥200 c/mL), and experienced intimate partner violence (IPV) (past 12 months) predicted inflammatory and type I IFN gene expression in HIV-positive Black and Latinx men who have sex with men (MSM). Methods: Participants were 147 HIV-positive Black and Latinx MSM recruited from the mSTUDY, a cohort of 561 MSM aged 18–45 in Los Angeles, CA, of whom half are HIV-positive and substance-using. Transcriptomic measures of inflammatory and type I IFN activity were derived from RNA sequencing of peripheral blood mononuclear cells and matched to urine drug tests, VL, and survey data across two time points 12 months apart. Analysis used linear random intercept modeling of MA use, unsuppressed VL, and experienced IPV on inflammatory and type I IFN expression. Results: In adjusted models, MA use predicted 27% upregulated inflammatory and 31% upregulated type I IFN expression; unsuppressed VL predicted 84% upregulated type I IFN but not inflammatory expression; and experienced IPV predicted 31% upregulated inflammatory and 26% upregulated type I IFN expression. Conclusions: In Black and Latinx MSM with HIV, MA use, unsuppressed VL, and experienced IPV predicted upregulated social genomic markers of immune functioning. Abstract : Men living with HIV who used methamphetamine, were virally unsuppressed, and experienced social adversity showed increased activation of proinflammatory and antiviral genes.